Curium Announces Plan to Submit an Application to Market Generic Ioflupane I 123 Injection in the U.S. St. Louis MO, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Curium announced today that it intends to submit an abbreviated new drug application for a generic version of DaTscanTM (Ioflupane I 123 Injection) in...